White Paper

Difficult-To-Purify And Difficult-To-Filter Small Molecules: A Framework For Downstream Process Development

trialkit-api-GettyImages-2223712653

A promising API can be synthesized efficiently and still fail commercially if it cannot be purified economically or isolated in a form suited to large-scale manufacturing. PROTACs, ADC linker-payloads, and highly functionalized APIs make that risk more common. The authors, Bertram Cezanne, Axel Becker, and Benjamine Hale, argue that filtration and purification problems share molecular origins and are best addressed together. The paper examines why crystallization is more than an isolation step, what changes when chromatography enters the process, and how fraction mapping and predictive modeling shape scale-up decisions. It also weighs the tradeoffs among yield, purity, particle properties, and process economics.

Access the full white paper to see how these decisions fit together in a single development strategy.

Access The White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online